Expanded Indication: Hemospray Endoscopic Hemostat

Unlike traditional therapies, Hemospray is a nonthermal, nontraumatic, noncontact modality that doesn’t require the precise targeting of other endoscopic devices. The Hemospray Endoscopic Hemostat creates a mechanical barrier over bleeding sites, and it has demonstrated successful results in a wide range of nonvariceal GI bleeds. After presenting clinical data on Hemospray’s safety and performance on bleeds, the indications have been expanded to include use in the lower GI tract. Now, with a CE marking for treatment of nonvariceal bleeds in the entire GI tract, Hemospray provides more utility than ever.

Clinical data demonstrates Hemospray’s high success rates

Peer-reviewed publications from the largest multicentre international registry of Hemospray patients shows high haemostasis rates and also shows rebleed rates that are in keeping with or lower than predicted rates.^1,3,4 The registry also investigates the efficacy of Hemospray as monotherapy, as combination therapy, and as rescue therapy.

Learn more about the data

‘Hemospray provides a promising alternative bridging option towards definitive treatment with surgery/radiotherapy in [peptic ulcer-related bleeding] patients. … Patients can be stabilized and planned for the appropriate definitive intervention.’¹

‘Treatment with Hemospray significantly reduced transfusion requirements (P < 0.001). The significant improvement in transfusion requirements remained when Hemospray was used as a monotherapy.'¹

See more data

Explore our haemostasis devices

1. Hussein M, Alzoubaidi D, Lopez M-F, et al. Hemostatic spray powder TC-325 in the primary endoscopic treatment of peptic ulcer-related bleeding: multicenter international registry. Endoscopy. 2021;53(1):36–43.

3. Hussein M, Alzoubaidi D, O’Donnell M, et al. Hemostatic powder TC-325 treatment of malignancyrelated upper gastrointestinal bleeds: international registry outcomes. J Gastroenterol Hepatol. 2021. doi: 10.1111/jgh.15579. Epub ahead of print. PMID: 34132412

4. Alzoubaidi D, Hussein M, Rusu R, et al. Outcomes from an international multicenter registry of patients with acute gastrointestinal bleeding undergoing endoscopic treatment with Hemospray. Dig Endosc. 2020;32(1):96–105.